Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Sep;46(9):1247-1252.
doi: 10.1097/j.jcrs.0000000000000212.

Comparison of clinical outcomes of 3 trifocal IOLs

Filomena Ribeiro  1 , Tiago B Ferreira
Affiliations
Randomized Controlled Trial

Comparison of clinical outcomes of 3 trifocal IOLs

Filomena Ribeiro et al. J Cataract Refract Surg. 2020 Sep.

Abstract

Purpose: To compare the clinical outcomes obtained after implantation of 1 of 3 models of diffractive trifocal IOLs.

Setting: Hospital da Luz, Lisbon, Portugal.

Design: Prospective randomized comparative study.

Methods: Patients undergoing cataract surgery with bilateral implantation of 1 of 3 models of diffractive trifocal IOLs were enrolled. The IOL models implanted were the FineVision POD F, RayOne Trifocal, or the AcrySof IQ PanOptix IOL (30 eyes of 15 patients in each group). Visual acuity (VA), refraction, defocus curve, and contrast sensitivity outcomes were evaluated during a 3-month follow-up. Furthermore, the Quality of Vision questionnaire (QoV) was used to evaluate the frequency, severity, and discomfort of different visual symptoms.

Results: A total of 90 eyes of 45 patients were included. No statistically significant differences were found between groups in distance, intermediate, and near VA (P ≥ .112) and postoperative refraction (P ≥ .059). Postoperative binocular uncorrected intermediate VA of 0.10 logarithm of the minimum angle of resolution (logMAR) or better was found in 14 (93.33%) patients in the 3 groups. Postoperative binocular uncorrected near VA of 0.10 logMAR or better was found in 13 (86.67%), 14 (93.33%), and 13 (86.67%) patients in the POD F, RayOne, and PanOptix IOLs groups, respectively. No statistically significant differences were found between groups in scotopic contrast sensitivity with and without glare and in the QoV scores (P ≥ .057), except for the difference between the POD F and RayOne IOLs groups in depth perception severity, which was less in the RayOne IOL group (P = .019).

Conclusions: The 3 trifocal IOLs evaluated provided a complete visual restoration with good visual quality outcomes.

PubMed Disclaimer

References

    1. Ferreira TB, Ribeiro FJ. Prospective comparison of clinical performance and subjective outcomes between two diffractive trifocal intraocular lenses in bilateral cataract surgery. J Refract Surg 2019;35:418–425
    1. Sezgin Asena B. Visual and refractive outcomes, spectacle independence, and visual disturbances after cataract or refractive lens exchange surgery: comparison of 2 trifocal intraocular lenses. J Cataract Refract Surg 2019;45:1539–1546
    1. Fernández J, Rodríguez-Vallejo M, Martínez J, Tauste A, Piñero DP. Standard clinical outcomes with a new low addition trifocal intraocular lens. J Refract Surg 2019;35:214–221
    1. Javaloy J, Rivera E, Montalbán R, Beltrán J, Muñoz G, Rohrweck S. Diffractive trifocal pseudophakic intraocular lenses in high myopic eyes: 2-year assessment after implantation. Graefes Arch Clin Exp Ophthalmol 2019;257:1331–1339
    1. Fernández J, Rodríguez-Vallejo M, Martínez J, Tauste A, Piñero DP. Patient selection to optimize near vision performance with a low-addition trifocal lens. J Optom 2020;13(1):50–58

Publication types